Plunkett Research Online: Esperion Therapeutics Inc

ESPERION THERAPEUTICS INC (ESPR:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

A biopharmaceutical company.....

Esperion Therapeutics Inc
Ticker: ESPR
Exchange: NAS
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 734 862-4840
Address: 3891 Ranchero Drive
Suite 150
Ann Arbor, MI 48108 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description

Timothy Mayleben CEO/Director/President
Richard Bartram Chief Accounting Officer/Secretary/CFO
See More
A biopharmaceutical company.....See More See More

Auditor: EY
Legal Advisor: Goodwin Procter LLP
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: